About Signova Pharma
Signova Pharma is a Healthcare company. Pharmaceutical product development and distribution in healthcare. The company has 421 employees. Its Indian entity Signova Pharma Private Limited reported revenue of βΉ131 Cr. Signova Pharma offers products and services including Rabsig DSR and Raxclav 625. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medications and Medical Supplies.
Company details
Signova Pharma has been established since January 2008, where consistent efforts are made to pursue excellence in healthcare services through the development of safe and efficacious products. The companys range is updated regularly with the latest molecules to foster a healthy society, as initiatives are taken for sustainable growth and a strong industry position. Valuable efforts are directed towards serving humanity and providing quality pharmaceutical offerings across 26 categories, ensuring multi-lateral growth is achieved without promotional emphasis.
- Employees 421
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website signovapharma.com
- Social Facebook
- Legal Name Signova Pharma Pvt. Ltd
- Date of Incorporation 04 Jan, 2008
- Jurisdiction Guwahati, Assam, India
- Indian entity revenue₹131 Cr
FY 2025 · 0% YoY
- Indian entity net profit₹6.79 Cr
FY 2025 · 5% margin
- Indian entity EBITDA₹11.66 Cr
FY 2025 · 9% margin
- Employee Count421
Associated legal entities of Signova Pharma
Signova Pharma operates through Signova Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Signova Pharma Private Limited CIN U51397AS2008PTC008558 | Active | 04 Jan 2008 | Guwahati, Assam | ₹131 Cr | 421 | 2 | View details |
Products & Services of Signova Pharma
Signova Pharma offers a comprehensive portfolio of products and services, including Rabsig DSR and Raxclav 625.
This product is provided as part of the company's range aimed at delivering safe and efficacious healthcare solutions.
This product is included among the offerings that are updated with the latest molecules to support quality healthcare.
Board of directors of Signova Pharma Private Limited (Signova Pharma)
Signova Pharma Private Limited is the primary company behind Signova Pharma. The board of Signova Pharma Private Limited currently have 2 directors; the longest-serving is Satrajit Kanungo, appointed in 2008.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satrajit Kanungo DIN 00005002 | Director | 04 Jan 2008 | 18 yrs 10 mo | Signova Pharma Private Limited |
| Ranjan Kumar Deka DIN 01157216 | Director | 04 Jan 2008 | 18 yrs 10 mo | Signova Pharma Private Limited |
Financials of Signova Pharma
Figures of Signova Pharma Private Limited, the primary company behind Signova Pharma, for FY 2025. Revenue was ₹131 Cr (0% year on year). Net profit was ₹6.79 Cr (5% margin). EBITDA was ₹11.66 Cr (9% margin). Revenue has grown at a compounded annual rate of +17% over three years and +16% over five years.
- ₹131 CrRevenue · FY 2025 · 0% YoY
- ₹6.79 CrNet profit · 5% margin
- ₹11.66 CrEBITDA · 9% margin
- ₹40 LakhPaid-up capital
- 421Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Signova Pharma Private Limited are on its company page.
Detailed financial statements for Signova Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Signova Pharma
Signova Pharma has 421 employees.
The primary company behind Signova Pharma, Signova Pharma Private Limited, reported revenue of βΉ131 Cr for FY 2025, down 0% year on year.
Signova Pharma has been established since January 2008, where consistent efforts are made to pursue excellence in healthcare services through the development of safe and efficacious products. The companys range is updated regularly with the latest molecules to foster a healthy society, as initiatives are taken for sustainable growth and a strong industry position. Valuable efforts are directed towards serving humanity and providing quality pharmaceutical offerings across 26 categories, ensuring multi-lateral growth is achieved without promotional emphasis.
Signova Pharma offers Rabsig DSR and Raxclav 625.
Signova Pharma operates through Signova Pharma Private Limited.
The legal entities of Signova Pharma currently have 2 directors, including Satrajit Kanungo, Ranjan Kumar Deka.
